Search This Blog

Thursday, August 6, 2020

Puma Biotechnology EPS beats by $0.20, beats on revenue

Puma Biotechnology (NASDAQ:PBYI): Q2 Non-GAAP EPS of $0.35 beats by $0.20; GAAP EPS of $0.08 beats by $0.38.
Revenue of $70.6M (+31.0% Y/Y) beats by $12.39M.
Press Release

Posted by at

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.

Subscribe to: Post Comments (Atom)